C-Reactive Protein Level: A Key Predictive Marker of Cachexia in Lymphoma and Myeloma Patients.
Fiche publication
Date publication
juin 2019
Journal
Journal of hematology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MALLARD Joris
Tous les auteurs :
Mallard J, Gagez AL, Baudinet C, Herbinet A, Maury J, Bernard PL, Cartron G
Lien Pubmed
Résumé
Cachexia is defined as an involuntary loss of weight, characterized by a loss of skeletal muscle mass with or without fat mass loss. It increases mortality risk and decreases quality of life in patients with lymphoma or myeloma. Early markers of cachexia are not identified. The objective of this work was to identify risk factor of cachexia in a cohort of patients with hematological malignancies to develop strategies to prevent cachexia and its consequences.
Mots clés
CRP, Cachexia, Inflammation, Lymphoma, Myeloma
Référence
J Hematol. 2019 06;8(2):55-59